AIBMR Life Sciences, Inc., 1425 Broadway, Suite 458, Seattle, Washington, 98122, USA.
Toxi-Coop Zrt., Berlini utca 47-49, H-1045, Budapest, Hungary.
J Appl Toxicol. 2023 Jun;43(6):887-912. doi: 10.1002/jat.4432. Epub 2023 Jan 26.
Microorganisms have the potential to produce nutrient-rich products that can be consumed as food or feed. The protein-rich powder derived from heat treatment of the whole-cell biomass of polyhydroxybutyrate-deficient Cupriavidus necator, a metabolically versatile organism that uses elements found in the air, is an example of such a product. To assess the safety of the protein powder for use as a nutritional ingredient in human food, in accordance with internationally accepted standards, its genotoxic potential and repeated-dose oral toxicity were investigated. A bacterial reverse mutation test, an in vitro mammalian chromosomal aberration test, and an in vivo mammalian micronucleus test were performed. No evidence of mutagenicity or genotoxicity was found. Additionally, a 90-day repeated-dose oral toxicity study in rats was completed, in which a total of 100 male and female Wistar rats were exposed by gavage to daily doses of 1000, 2000, or 3000 mg/kg bw/day of the test material. Following 90 days of continuous exposure, no mortality or treatment-related adverse effects were observed and no target organs were identified. Therefore, a no observed adverse effect level was determined at 3000 mg/kg bw/day, the highest dose tested.
微生物具有生产富含营养的产品的潜力,这些产品可以作为食物或饲料食用。从缺乏聚羟基丁酸的铜绿假单胞菌全细胞生物质经热处理得到的富含蛋白质的粉末就是这样一种产品,该菌是一种代谢多功能的生物体,能够利用空气中的元素。为了按照国际公认的标准评估该蛋白质粉末作为人类食物营养成分的安全性,对其遗传毒性潜力和重复剂量口服毒性进行了研究。进行了细菌回复突变试验、体外哺乳动物染色体畸变试验和体内哺乳动物微核试验。未发现致突变性或遗传毒性的证据。此外,还完成了一项为期 90 天的重复剂量口服毒性大鼠研究,共有 100 只雄性和雌性 Wistar 大鼠通过灌胃每日接受 1000、2000 或 3000mg/kg bw/day 的试验材料,连续暴露 90 天。未观察到死亡率或与治疗相关的不良反应,也未确定靶器官。因此,在最高测试剂量 3000mg/kg bw/day 下确定了无观察不良效应水平。